-
Sector Analysis
Endometriosis Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2034
This report covers the 7MM (US, France, Germany, Italy, Spain, UK, Japan) and provides an Excel-based forecast model for the Endometriosis market through 2034. GlobalData estimates the 2024 sales for the endometriosis market at approximately $938.0 million across the 7MM, encompassing the US, the 5EU, and Japan. By 2034, GlobalData expects the overall market to grow at a compound annual growth rate (CAGR) of 10.3% to reach sales of $2.5 billion over the 10-year period. The US market will grow...
-
Sector Analysis
Endometriosis Epidemiology Analysis and Forecast to 2034
Endometriosis is a chronic disease, and is defined as the presence of functional endometrial mucosa outside the uterine cavity, often in the pelvis, but also more rarely in locations such as the pericardium, pleura cavity, and even in the brain tissue (World Health Organization, 2025). It is one of the most common benign gynecological diseases in pre-menopausal women, and affects roughly 10–15% of reproductive age women and girls globally (World Health Organization, 2025). Normally, endometrial tissue or endometrium forms the...
-
Product Insights
Endometriosis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2025 Update
GlobalData's clinical trial report, “Endometriosis - Global Clinical Trials Review, 2025" provides an overview of Endometriosis Clinical trials scenario. This report provides top line data relating to the clinical trials on Endometriosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Sector Analysis
Dysmenorrhea Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Dysmenorrhea Marketed and Pipeline Drugs Report Overview Dysmenorrhea (DM) is uterine pain, which may occur with menses or precede menses by one to three days. It is often crampy or a dull constant ache but may be sharp or throbbing, which may radiate to the back or legs. DM is sometimes accompanied by symptoms of premenstrual syndrome (PMS) or heavy menstrual bleeding and passage of blood clots. Key Mechanisms of Action (Marketed) · Enzyme Inhibitors · Receptor Antagonists · Receptor...
-
Sector Analysis
Female Infertility in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2033
Reasons to buy the ‘Female Infertility’ market report: Assess annualized female infertility therapeutics market revenue, cost of therapy per patient, and treatment usage patterns forecast from 2023 to 2033. Get access to key topics including strategic competitor assessment, market characterization, unmet needs, clinical trial mapping, and implications of these factors for the female infertility therapeutics market. Detailed pipeline analysis, with comprehensive data assessing, emerging trends and mechanisms of action under development for female infertility treatment. The most promising candidates in...
-
Sector Analysis
Female Infertility Epidemiology Analysis and Forecast to 2033
Female Infertility Report Overview In the 7MM, there were 420,793 diagnosed incident cases of female infertility in 2023. The diagnosed incident cases of female infertility will decline at an AGR of less than 1% during 2023-2033. The major causative factors of infertility and impaired fecundity are fallopian tube dysfunction, disorders of menstruation, sexual disorders, increasing age, and in a very small percentage of patients, ovarian failure. Female Infertility Market Outlook, 2023-2033 (Diagnosed Incident Cases) Buy the Full Report for More...
-
Sector Analysis
Female Infertility in 68 Markets - Disease Overview, Product Profiles, Patient Flow, Competitive Assessment and Sales Forecast to 2033
Female Infertility Market Report Overview The female infertility market size across the 68 M was $3 billion in 2023. The “Female Infertility in 68 Markets” research report covers the 68 geographical markets and provides an Excel-based forecast model for the market through 2033. Female Infertility Market Outlook, 2023-2033 ($ Billion) Buy the Full Report for More Insights on the Female Infertility Market Report Forecast Download a Free Report Sample The Female Infertility market report contains patient-based forecast sales data for...
-
Product Insights
Endometriosis - Drugs In Development, 2024
Empower your strategies with our Endometriosis – Drugs In Development, 2024 report and make more profitable business decisions. Endometriosis is an often painful disorder in which tissue that normally lines the inside of uterus (endometrium) grows outside uterus (endometrial implant). Symptoms include pelvic pain, menstrual cramps, inflammation, infertility, and abnormal bleeding. Risk factors include age, uterine abnormalities, history of pelvic infection, and family history. Treatment includes non-steroidal anti-inflammatory drugs (NSAIDs), birth control pills, and progestins. The Endometriosis drugs in development market...
-
Product Insights
Female Contraception - Drugs In Development, 2024
Empower your strategies with our Female Contraception – Drugs In Development, 2024 report and make more profitable business decisions. Contraception (birth control) prevents pregnancy by interfering with the normal process of ovulation, fertilization, and implantation. There are many contraceptive methods which include implants and injections, intrauterine devices (IUDs), pills and vaginal rings, barrier methods, sterilization, and "natural" methods. Contraception generally works by preventing sperm from reaching and fertilizing an egg (barrier and IUD methods), preventing an egg from being released every...
-
Product Insights
Ovarian Disease - Drugs In Development, 2024
Empower your strategies with our Ovarian Disease – Drugs In Development, 2024 report and make more profitable business decisions. Ovarian disease is a term for various conditions that affect the ovaries, which are the female reproductive organs that produce eggs and hormones. The most common ovarian diseases include polycystic ovary syndrome (PCOS), a hormonal disorder that causes irregular periods, excess androgen, and multiple cysts on the ovaries. PCOS can affect fertility and increase the risk of diabetes and heart disease. Another...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.